• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状RNA沉默调节蛋白1通过靶向微小RNA-145-5p/蛋白激酶B3轴抑制肺动脉平滑肌细胞增殖、迁移和自噬,从而改善肺动脉高压。

Circular RNA Sirtuin1 represses pulmonary artery smooth muscle cell proliferation, migration and autophagy to ameliorate pulmonary hypertension via targeting microRNA-145-5p/protein kinase-B3 axis.

作者信息

Jing Xiaogang, Wu Shujun, Liu Ying, Wang Huan, Huang QingFeng

机构信息

Department of Respiratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, Henan Province, China.

Zhibang Biological Laboratory, Guangzhou Science City Incubation Base, Guangzhou City, Guangdong Province, 510000, China.

出版信息

Bioengineered. 2022 Apr;13(4):8759-8771. doi: 10.1080/21655979.2022.2036302.

DOI:10.1080/21655979.2022.2036302
PMID:35369850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9161928/
Abstract

Recently, several studies have been clarified that circular RNA (circRNA) was a vital regulatory gene of pulmonary hypertension (PH). Nevertheless, the action of circRNA in PH was not yet explored. This study was to figure out the biological function and potential molecular mechanism of circSirtuin1 (SIRT1) in PH. Construction of the PH rat model and hypoxia pulmonary artery smooth muscle cells (PASMC) model was performed, and test of circSIRT1/microRNA (miR)-145-5p/protein kinase-B3 (Akt3) was conducted. The influence of the circSIRT1/miR-145-5p/Akt3 axis on the histopathology, hemodynamics with autophagy of the pulmonary artery in rats was examined. Additionally, the impact of circSIRT1/miR-145-5p/Akt3 on the proliferation, migration and apoptosis with autophagy of PASMC under hypoxic environment was also determined. The targeting of circSIRT1/miR-145-5p/Akt3 was testified. The results manifested that circSIRT1 and Akt3 were elevated in PH, while miR-145-5p was declined. Knockdown of circSIRT1 ameliorated rat PH, suppressed PASMC proliferation, migration with autophagy in hypoxic environment. CircSIRT1 competitively combined with miR-145-5p to mediate Akt3. To sum up, circSIRT1/miR-145-5p/Akt3 was supposed to perform as a prospective molecular target for the treatment of PH.

摘要

最近,多项研究已阐明环状RNA(circRNA)是肺动脉高压(PH)的重要调控基因。然而,circRNA在PH中的作用尚未得到探索。本研究旨在明确环状沉默调节蛋白1(circSirtuin1,circSIRT1)在PH中的生物学功能及潜在分子机制。构建了PH大鼠模型和缺氧肺动脉平滑肌细胞(PASMC)模型,并进行了circSIRT1/微小RNA(miR)-145-5p/蛋白激酶B3(Akt3)检测。研究了circSIRT1/miR-145-5p/Akt3轴对大鼠肺动脉组织病理学、血流动力学及自噬的影响。此外,还确定了circSIRT1/miR-145-5p/Akt3对缺氧环境下PASMC增殖、迁移、凋亡及自噬的影响。验证了circSIRT1/miR-145-5p/Akt3的靶向作用。结果表明,PH中circSIRT1和Akt3升高,而miR-145-5p降低。敲低circSIRT1可改善大鼠PH,抑制缺氧环境下PASMC的增殖、迁移及自噬。circSIRT1与miR-145-5p竞争性结合以介导Akt3。综上所述,circSIRT1/miR-145-5p/Akt3有望成为治疗PH的潜在分子靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/26075f4e4e69/KBIE_A_2036302_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/88431a914f32/KBIE_A_2036302_UF0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/732717059676/KBIE_A_2036302_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/949cc749921f/KBIE_A_2036302_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/e693b4c3f13a/KBIE_A_2036302_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/b10a3c3e571f/KBIE_A_2036302_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/323341ac8ef1/KBIE_A_2036302_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/30431140dcc8/KBIE_A_2036302_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/26075f4e4e69/KBIE_A_2036302_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/88431a914f32/KBIE_A_2036302_UF0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/732717059676/KBIE_A_2036302_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/949cc749921f/KBIE_A_2036302_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/e693b4c3f13a/KBIE_A_2036302_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/b10a3c3e571f/KBIE_A_2036302_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/323341ac8ef1/KBIE_A_2036302_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/30431140dcc8/KBIE_A_2036302_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b45e/9161928/26075f4e4e69/KBIE_A_2036302_F0007_OC.jpg

相似文献

1
Circular RNA Sirtuin1 represses pulmonary artery smooth muscle cell proliferation, migration and autophagy to ameliorate pulmonary hypertension via targeting microRNA-145-5p/protein kinase-B3 axis.环状RNA沉默调节蛋白1通过靶向微小RNA-145-5p/蛋白激酶B3轴抑制肺动脉平滑肌细胞增殖、迁移和自噬,从而改善肺动脉高压。
Bioengineered. 2022 Apr;13(4):8759-8771. doi: 10.1080/21655979.2022.2036302.
2
Circular RNA sirtuin-1 restrains the malignant phenotype of non-small cell lung cancer cells via the microRNA-510-5p/SMAD family member 7 axis.环状 RNA 沉默信息调节因子 1 通过 microRNA-510-5p/SMAD 家族成员 7 轴抑制非小细胞肺癌细胞的恶性表型。
Acta Biochim Pol. 2023 Oct 18;70(4):855-863. doi: 10.18388/abp.2020_6675.
3
MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.微小 RNA-221-3p 通过靶向 AXIN2 促进肺动脉平滑肌细胞增殖在肺动脉高压中。
Vascul Pharmacol. 2019 May;116:24-35. doi: 10.1016/j.vph.2017.07.002. Epub 2017 Jul 8.
4
MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1.miR-593-5p 通过靶向 PLK1 促进低氧诱导的肺动脉高压的发展。
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3495-3502. doi: 10.26355/eurrev_201904_17715.
5
CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR-509-5p/multiple C2 and transmembrane domain containing 2 axis.环状 RNA ST6GAL1 敲低通过调节 miR-509-5p/多个 C2 和跨膜域蛋白 2 轴缓解肺动脉高压。
Clin Respir J. 2024 May;18(5):e13771. doi: 10.1111/crj.13771.
6
The HIF-1α/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy.HIF-1α/miR-26a-5p/PFKFB3/ULK1/2 轴通过自噬调节缺氧诱导的肺动脉高压中的血管重构。
FASEB J. 2023 May;37(5):e22906. doi: 10.1096/fj.202200699RR.
7
MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension.miR-18a-5p 通过靶向 Notch2 促进肺动脉平滑肌细胞的增殖和迁移,从而导致肺动脉高压。
Life Sci. 2020 Sep 15;257:117919. doi: 10.1016/j.lfs.2020.117919. Epub 2020 Jun 22.
8
Inhibition of miR-4640-5p alleviates pulmonary hypertension in chronic obstructive pulmonary disease patients by regulating nitric oxide synthase 1.抑制 miR-4640-5p 通过调节一氧化氮合酶 1 缓解慢性阻塞性肺疾病患者的肺动脉高压。
Respir Res. 2023 Mar 24;24(1):92. doi: 10.1186/s12931-023-02387-5.
9
Exosomal miR-663b from "M1" macrophages promotes pulmonary artery vascular smooth muscle cell dysfunction through inhibiting the AMPK/Sirt1 axis.“M1”巨噬细胞来源的外泌体 miR-663b 通过抑制 AMPK/Sirt1 轴促进肺动脉血管平滑肌细胞功能障碍。
Aging (Albany NY). 2023 May 4;15(9):3549-3571. doi: 10.18632/aging.204690.
10
Restoration of miR-328a-5p function curtails hypoxic pulmonary hypertension through a mechanism involving PIN1/GSK3β/β-catenin axis.miR-328a-5p 功能的恢复通过涉及 PIN1/GSK3β/β-catenin 轴的机制来限制低氧性肺动脉高压。
Int Immunopharmacol. 2023 Oct;123:110599. doi: 10.1016/j.intimp.2023.110599. Epub 2023 Aug 9.

引用本文的文献

1
CircRNA-based AntimiR therapy: A novel approach to hypertension treatment.基于环状RNA的抗miR治疗:高血压治疗的新方法。
Noncoding RNA Res. 2025 May 5;13:94-108. doi: 10.1016/j.ncrna.2025.05.001. eCollection 2025 Aug.
2
[circ_0084043/miR-31-5p Is Involved in Atherosclerosis by Regulating HMGA1: Investigation of the Mechanisms].[环状RNA_0084043/微小RNA-31-5p通过调控高迁移率族蛋白A1参与动脉粥样硬化:机制研究]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 20;55(6):1533-1542. doi: 10.12182/20241160506.
3
CircRNA-mediated regulation of cardiovascular disease.

本文引用的文献

1
Hsa_circ_0001666 suppresses the progression of colorectal cancer through the miR-576-5p/PCDH10 axis.Hsa_circ_0001666 通过 miR-576-5p/PCDH10 轴抑制结直肠癌的进展。
Clin Transl Med. 2021 Nov;11(11):e565. doi: 10.1002/ctm2.565.
2
Circ-SIRT1 inhibits cardiac hypertrophy via activating SIRT1 to promote autophagy.Circ-SIRT1 通过激活 SIRT1 促进自噬来抑制心肌肥厚。
Cell Death Dis. 2021 Nov 10;12(11):1069. doi: 10.1038/s41419-021-04059-y.
3
Ketogenic diet aggravates kidney dysfunction by exacerbating metabolic disorders and inhibiting autophagy in spontaneously hypertensive rats.
环状RNA对心血管疾病的调控
Front Cardiovasc Med. 2024 Nov 26;11:1411621. doi: 10.3389/fcvm.2024.1411621. eCollection 2024.
4
Superenhancer-driven circRNA Myst4 involves in pulmonary artery smooth muscle cell ferroptosis in pulmonary hypertension.超级增强子驱动的环状RNA Myst4参与肺动脉高压中肺动脉平滑肌细胞的铁死亡。
iScience. 2024 Sep 12;27(10):110900. doi: 10.1016/j.isci.2024.110900. eCollection 2024 Oct 18.
5
Emerging connectivity of programmed cell death pathways and pulmonary vascular remodelling during pulmonary hypertension.细胞程序性死亡通路与肺动脉高压中肺血管重构的新兴关联。
J Cell Mol Med. 2024 Aug;28(16):e70003. doi: 10.1111/jcmm.70003.
6
Long Noncoding RNA MALAT1: Salt-Sensitive Hypertension.长链非编码 RNA MALAT1:盐敏感性高血压。
Int J Mol Sci. 2024 May 18;25(10):5507. doi: 10.3390/ijms25105507.
7
CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR-509-5p/multiple C2 and transmembrane domain containing 2 axis.环状 RNA ST6GAL1 敲低通过调节 miR-509-5p/多个 C2 和跨膜域蛋白 2 轴缓解肺动脉高压。
Clin Respir J. 2024 May;18(5):e13771. doi: 10.1111/crj.13771.
8
Exploring the Multifaceted Biologically Relevant Roles of circRNAs: From Regulation, Translation to Biomarkers.探索 circRNAs 的多方面生物学相关作用:从调控、翻译到生物标志物。
Cells. 2023 Dec 10;12(24):2813. doi: 10.3390/cells12242813.
9
Epigenetic regulation of programmed cell death in hypoxia-induced pulmonary arterial hypertension.低氧诱导肺动脉高压中程序性细胞死亡的表观遗传调控。
Front Immunol. 2023 Sep 11;14:1206452. doi: 10.3389/fimmu.2023.1206452. eCollection 2023.
10
Advances in epigenetic modifications of autophagic process in pulmonary hypertension.肺高血压中自噬过程的表观遗传修饰的研究进展。
Front Immunol. 2023 Jun 16;14:1206406. doi: 10.3389/fimmu.2023.1206406. eCollection 2023.
生酮饮食通过加剧代谢紊乱和抑制自发性高血压大鼠的自噬来加重肾功能障碍。
Biochem Biophys Res Commun. 2021 Oct 8;573:13-18. doi: 10.1016/j.bbrc.2021.08.003. Epub 2021 Aug 3.
4
Hsa_circ_0002062 Promotes the Proliferation of Pulmonary Artery Smooth Muscle Cells by Regulating the Hsa-miR-942-5p/CDK6 Signaling Pathway.Hsa_circ_0002062通过调控Hsa-miR-942-5p/CDK6信号通路促进肺动脉平滑肌细胞增殖。
Front Genet. 2021 Jul 12;12:673229. doi: 10.3389/fgene.2021.673229. eCollection 2021.
5
CircRNA_0026344 via exosomal miR-21 regulation of Smad7 is involved in aberrant cross-talk of epithelium-fibroblasts during cigarette smoke-induced pulmonary fibrosis.环状 RNA_0026344 通过外泌体 miR-21 调控 Smad7 参与香烟烟雾诱导的肺纤维化中上皮细胞-成纤维细胞的异常串扰。
Toxicol Lett. 2021 Sep 1;347:58-66. doi: 10.1016/j.toxlet.2021.04.017. Epub 2021 May 4.
6
Hsa_circ_0030042 regulates abnormal autophagy and protects atherosclerotic plaque stability by targeting eIF4A3.人源环状RNA hsa_circ_0030042通过靶向真核翻译起始因子4A3(eIF4A3)调节异常自噬并保护动脉粥样硬化斑块稳定性。
Theranostics. 2021 Mar 12;11(11):5404-5417. doi: 10.7150/thno.48389. eCollection 2021.
7
Atractylon Treatment Attenuates Pulmonary Fibrosis via Regulation of the mmu_circ_0000981/miR-211-5p/TGFBR2 Axis in an Ovalbumin-Induced Asthma Mouse Model.白术治疗通过调节 mmu_circ_0000981/miR-211-5p/TGFBR2 轴减轻卵清蛋白诱导的哮喘小鼠模型中的肺纤维化。
Inflammation. 2021 Oct;44(5):1856-1864. doi: 10.1007/s10753-021-01463-6. Epub 2021 Apr 14.
8
Circular RNA-HIPK3 regulates human pulmonary artery endothelial cells function and vessel growth by regulating microRNA-328-3p/STAT3 axis.环状RNA-HIPK3通过调控微小RNA-328-3p/信号转导和转录激活因子3轴来调节人肺动脉内皮细胞功能和血管生长。
Pulm Circ. 2021 Mar 29;11(2):20458940211000234. doi: 10.1177/20458940211000234. eCollection 2021 Apr-Jun.
9
Circ_0001806 Promotes the Proliferation, Migration and Invasion of NSCLC Cells Through miR-1182/NOVA2 Axis.Circ_0001806通过miR-1182/NOVA2轴促进非小细胞肺癌细胞的增殖、迁移和侵袭。
Cancer Manag Res. 2021 Apr 8;13:3067-3077. doi: 10.2147/CMAR.S290059. eCollection 2021.
10
Up-regulation of circRNA_0068481 promotes right ventricular hypertrophy in PAH patients via regulating miR-646/miR-570/miR-885.环状 RNA_0068481 通过调控 miR-646/miR-570/miR-885 促进肺动脉高压患者右心室肥厚。
J Cell Mol Med. 2021 Apr;25(8):3735-3743. doi: 10.1111/jcmm.16164. Epub 2021 Mar 12.